Skip to content

Efficacy and safety of lactulose for bowel preparation in patients with inflammatory bowel disease

Efficacy and safety of lactulose for bowel preparation in patients with inflammatory bowel disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071791
Enrollment
Unknown
Registered
2023-05-25
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Bowel Disease

Interventions

the Lactulose group:Patients used lactulose for bowel preparation.
the PEG group:Patients used PEG for bowel preparation.

Sponsors

Department of Gastroenterology, The Second Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: All patients with confirmed IBD or suspected IBD for at least 3 months, aged between 16-75 years and requiring a colonoscopy were invited to participate in our study

Exclusion criteria

Exclusion criteria: 1. Were clinical active UC and CD; 2. Were known or suspected gastrointestinal obstruction, bowel perforation, toxic colitis or megacolon, recent or active gastrointestinal bleeding; 3. Were congestive heart failure, severe renal failure; 4. Were severe dehydration or electrolyte disturbances; 5. Were pregnant; 6. Were allergic to PEG or Lactulose; 7. Were diabetics; 8. Were lactose or galactose intolerance; 9. Refused to participate in this study.

Design outcomes

Primary

MeasureTime frame
Boston Bowel Preparaton Score;incidence of adverse events;

Countries

China

Contacts

Public ContactLin Daopo

The Second Affiliated Hospital of Wenzhou Medical University

1009419972@qq.com+86 182 5775 1883

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026